Knee Steroid Injection and Blood Sugar Signatur

Completed

Conditions studied: Diabetes, Knee Osteoarthritis

In brief

A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All of them will be consented a week prior to the injection, when the CGM sensor will be applied to the back of the upper arm. This will be removed a week after the injection. KOOS survey as well as VAS will be administered. Adverse events (e.g., change in medication or hospitalization) will be monitored throughout the study.

Key facts

Study ID

NCT04317404

Run by

University of Texas Southwestern Medical Center

People needed

11

Starts

2020-11-01

Expected to finish

2022-11-30

Last updated by the study team

2023-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at the Parkland Outpatient Clinic
• Indication for unilateral knee joint steroid injection for the treatment of knee joint osteoarthritis

You may not qualify if…

• Less than 18 years old
• HbA1c > 12.0%
• steroid exposure in the 3 months prior to Visit 1
• 3 or more steroid injections in the preceding 12 months
• known contraindication to steroid injection (adverse reaction or allergy, active infection, INR > 3.0)
• lack of improvement with prior knee steroid injection
• change in diabetic medication regimen in the last 1 month
• significant change in diet within the last 1 month
• current use of aspirin
• allergy to adhesive
• planned MRI, XR, or CT during the 2-week study period

Where it is running

• Parkland Hospital — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.